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Abstract
Background
The presumptive approach of confirming malaria in health facilities leads to over-diagnosis
of malaria, over use of anti-malaria drugs and the risk of drug resistance development.
WHO recommends parasitological confirmation before treatment with artemisinin-based
combination therapy (ACT) in all suspected malaria patients. The use of malaria rapid diag-
nostic tests (mRDTs) would make it possible for prescribers to diagnose malaria at point-of-
care and better target the use of antimalarials. Therefore, a cost-effectiveness analysis
was performed on the introduction of mRDTs for management of malaria in under-five chil-
dren in a high transmission area in Ghana where presumptive diagnosis was the norm in
public health centres.
Methods
A cluster-randomised controlled trial where thirty-two health centres were randomised into
test-based diagnosis of malaria using mRDTs (intervention) or clinical judgement (control)
was used to measure the effect of mRDTs on appropriate treatment: ‘a child with a positive
reference diagnosis prescribed a course of ACT or a child with a negative reference diagno-
sis not given an ACT’. Cost data was collected from five purposively selected health centres
and used to estimate the health sector costs of performing an mRDT and treat children for
malaria and other common febrile illnesses. Costs of training healthcare personnel and
supervision in the study period were also collected. A sample of caregivers to children
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participating in the trial was interviewed about household cost incurred on transport, drugs,
fees, and special food during a period of one week after the health centre visit as well as
days unable to work. A decision model approach was used to calculate the incremental
cost-effectiveness ratios (ICERs). Univariate and multivariate sensitivity analyses were
applied to assess the robustness of ICERs.
Results
The availability of mRDTs for malaria diagnosis resulted in fewer ACT treatments com-
pared to the clinical judgement approach (73% versus 81%) and more children appropri-
ately treated (70% versus 57%). The introduction of mRDT-based diagnosis would cost the
Ministry of Health US$18.6 per extra appropriately treated child under five compared to clin-
ical judgement while the ICER from a societal perspective was lower at US$11.0 per appro-
priately treated child. ICERs were sensitive to a decrease in adherence to negative
mRDTs, malaria positivity rate and specificity of the mRDT.
Conclusion
The introduction of mRDTs is likely to be considered cost-effective in this high transmission
setting as this intervention increased the number of appropriately treated children at low
cost.
Trial Registration
ClinicalTrials.gov NCT00832754
Background
Malaria remains a major cause of morbidity and mortality in sub-Saharan African countries
with an estimated 188 million cases and 395,000 deaths in 2014 of which the majority occurred
in children below 5 years [1]. The use of the laboratory tests to confirm cases of malaria has
been a challenge for many years and the levels of transmission justified the presumptive
approach to its management [2]. However, presumptive management led to the over-diagnosis
of malaria and over use of antimalarial drugs in many settings and consequently contributed to
the selection of parasites resistant to chloroquine and sulphadoxine-pyrimethamine [3–6].
Over-diagnosis of malaria also led to the delayed appropriate treatment of non-malarial febrile
illnesses (NMFI) [7–11]. TheWorld Health Organization (WHO) recently updated the guide-
lines on malaria case management to recommend parasitological confirmation before treat-
ment in all suspectedmalaria patients including children under five years of age [12].
The use of malaria rapid diagnostic tests (mRDTs) would make it possible for prescribers to
diagnosemalaria at point-of-care and better target the use of antimalarials. This approach is
only now being scaled up in Ghana and the presumptive use of antimalarials in the manage-
ment of malaria is still practiced in many primary care facilities in the country. While the intro-
duction of mRDT diagnosis in a setting with presumptive diagnosis of malaria will likely
improve the targeting of antimalarials to children with parasites, the added cost of the mRDTs
is also an important consideration.
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Althoughmicroscopy performed by a competent laboratory technician under ideal condi-
tions is the gold standard for the diagnosis of malaria [13], its accuracy under operational con-
ditions in Africa can be quite low [14]. Several studies have shown that mRDT diagnosis is
more cost-effective than presumptive diagnosis in an era of expensive antimalarials such as
artemisinin-basedcombination therapy (ACT) [13,15–21]. This finding is however sensitive to
several factors of which malaria transmission level and adherence to negative test results by
healthcare providers appear as the most important [15,19,20,22].
A recently concluded cluster-randomised controlled trial in a high transmission region of
central Ghana evaluated the effect of restrictingACT treatment to mRDT-positive cases in
under-five children seeking care in primary public health centres [23]. The objectives of the
trial were to estimate the effect of mRDT introduction on appropriate treatment of malaria and
on the incidence of malaria or anaemia among under-five children. It was concluded that test-
basedmanagement of malaria improved quality of care, increased the number of children
appropriately treated and did not increase the risk of malaria among children in the area com-
pared to presumptive diagnosis of malaria. The present research built on this trial to develop a
cost-effectiveness analysis assessing the impact of introducingmRDTs for the treatment of
under-five children in a high transmission setting where presumptive diagnosis was the norm
in public health centres. This research will contribute to knowledge on the cost-effectiveness of
introducingmRDTs in a high transmission setting since previous cost-effectiveness analyses
have typically been conducted in low to medium transmission areas [13,16,19,21]. The trial uti-
lised for the cost-effectiveness analysis was registered in the online clinical trials registry as
NCT00832754 (ClinicalTrials.gov).
Methods
Study area
A detailed description of the study area has been published previously [24]. Briefly, the study
was conducted in Kintampo North Municipality, Kintampo South district, Techiman Munici-
pality, Nkoranza North and South and Tain districts in the Brong Ahafo region of Ghana. It
involved 32 health centres in the five districts. The catchment populations of these health cen-
tres range from 10,000 to 85,000. Malaria transmission in these areas is high and occurs all-
year round, and malaria is the leading diagnosis among under-fives in outpatient departments
in public health centres [25,26].
Study design
The study was a cost-effectiveness analysis which used data from a cluster-randomised, con-
trolled trial which compared the effects of mRDT-based diagnosis (intervention) versus clinical
judgement based-diagnosis (control) for treatment of malaria in public health centres in rural
Ghana [23]. In the intervention arm, children were offered ACT only when the mRDT result
was positive while in the control arm, children were given ACT on the basis of presenting clini-
cal signs and symptoms. In health centres of both arms, the approach to child assessment, clas-
sification and treatment for non-malaria illnesses followed guidelines of the Integrated
Management of Childhood Illness (IMCI).
In order to avoid the possible effect of financial barrier, the research project paid and
ensured that all the children participating in the trial were enrolled under the Ghana National
Health Insurance Scheme.
As recommended in the economic literature [27], the societal perspectivewas chosen for
the cost-effectiveness analysis and therefore included the costs to all those involved in the man-
agement of febrile illness including the health sector and the households of children suffering
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fever episodes. A cost-effectiveness analysis from a health sector perspectivewas also per-
formed to enable District Health Management Teams and country level health policymakers
to appreciate the estimated costs (and effects) of introducingmRDTs to the health system at
the health centre level.
Training
Health personnel attending to sick children at health centres in both arms participated in work-
shops where training in the management of malaria and other febrile illnesses according to
IMCI guidelines were offered as well as training on how to performmRDTs (intervention arm
only). This involved both didactic presentation of the guidelines and discussion sessions on
how to implement them. Training was conducted before the start of trial and repeated every
4–6 months until the end of the study. District field supervisors paid regular visits to participat-
ing health centres. Whenever a new health worker was transferred into any of the facilities, the
research team were alerted by the stationed fieldworker and training was organized and
conducted.
At each of the health centres, a trained research field officer was the first person to meet a
member of the cohort who was subsequently guided through the processes at the facility lead-
ing to attending by the healthcare personnel in the outpatient department. Quarterly review
meetings were held with the healthcare personnel and the research field officers at the health
centres. During these meetings, the objectives of the research, study allocation and the impor-
tance of adherence were repeated to the participants and refresher training was also provided.
Sampling
The unit of randomisation for the study arms was public health centres. Thirty-two health cen-
tres were stratified by districts, ranked within districts by the number of DPT1 vaccinations
given in the facility in the preceding year and paired according to the rank. From each pair of
health facilities one was randomly allocated to the intervention or control arm. All households
located within a 2 km radius of study health centres were enumerated and one hundred chil-
dren below 24 months of age living closest to the health centres were enrolled. Household cost
data was collected from children enrolled in 10 of the 32 health facilities (5 intervention and 5
control). Health facility cost data was collected from 5 purposively selected health centres
based upon logistical feasibility and a range of sizes, where size was defined as out-patient
attendance in 2010.
Measurement of effect
The measure of effect was ‘appropriate treatment of malaria with ACT’ which was a composite
indicator defined as a child with a positive reference diagnosis prescribed a course of ACT or a
child with a negative reference diagnosis not given an ACT. Reference diagnosis was by blood
slide double-read by two microscopists at the reference laboratory at the Kintampo Health
Research Centre and with discrepancies resolved through a reading by a third microscopist.
Over the two-year period of the trial, 5573 fever episodes were reported to a health centre by
children in the intervention arm while 5791 fever episodes by those in the control arm [23].
Information on malaria diagnosis by mRDT or clinical signs and symptoms as determined by
health centre staff, together with the medicines prescribedwere captured from all these visits.
Fieldworkers took blood samples for smear microscopy for later reference diagnosis from each
visit which enabled the classification of the treatment given as appropriate for malaria or not
according to the definition specified above.
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Measurement of costs
Training and supervisioncosts. Costs of training workshops to provide healthcare per-
sonnel in the participating health centres with refresher training in the management of febrile
illnesses and training on how to perform an mRDT (intervention arm only) were obtained
from the study financial accounts that had beenmaintained continuously during the study
period. Cost of supervision of health personnel at participating health centres was estimated by
interviewing supervisors about the frequency of supervisoryvisits, time per visit and their sal-
ary level. Supervisorycosts were estimated by study arm for the two-year trial period.
Health centre costs. Costs per service for a diagnosis by mRDT and treatment for malaria
and common non-malarial febrile illnesses were estimated based on data collection in five pub-
lic health centres in the study area. At each health centre, total recurrent expenditure for the
financial year 2011 were obtained on salaries, drugs, disposables, stationery, maintenance of
buildings, communication, utilities, transport and domestic expenses. This information was
available either from health centres themselves or at the District Office. Capital costs in the
financial year were estimated based on the construction costs of a standard health centre and
2011 prices of equipment and furniture found at the health centres. Since capital goods were
used for a longer time than one year, annual equivalents of the total costs of these were calcu-
lated using expected lifespans of 30, 7 and 10 years for buildings, equipment and furniture
respectively and a discount rate of 0.05 [27,28].
Total health centre costs for the financial year 2011 were allocated to final patient services
using the standard step-down costingmethodology [27,29]. Health centre costs by category
were distributed to overhead cost centres (administration, accounting, cleaning) and interme-
diate cost centres (dispensary, mRDT storage, diagnostics) and finally to patient cost centres
(direct patient care) in a step-wise fashion using allocation criteria expected to represent actual
resource use. For instance, salary expenditure was allocated to cost centres according to where
individual personnel spent their time on a typical day as captured through interviews.
Micro-costingmethods [30] were used to supplement the step-down costing in order to cal-
culate more accurately the services relevant for this study including the diagnosis of malaria
using mRDT and treatment of malaria and non-malarial febrile illnesses in the outpatient
department. The personnel responsible for performingmRDTs were interviewedon the time
spent per test based on which the salary cost per mRDT diagnosis could be calculated. The
price of the mRDT purchased for the study was US$0.82 as obtained from the study accounting
system. Malaria and non-malarial febrile illnesses were treated in the outpatient departments
of the health centres. Medical assistants and nurses were asked to estimate the required average
time used for an outpatient visit to treat these illnesses including taking illness history, measur-
ing temperature and prescribing drugs. Costs of drugs prescribed by diagnosis were estimated
based on the assumption that healthcare workers generally followed official clinical guidelines
and with cost per treatment dose obtained from RegionalMedical Stores. Taking care not to
double count, cost data from the step-down costingmethodologyand the micro-costingwere
combined to form full unit costs per mRDT test and outpatient treatments of malaria and non-
malarial febrile illnesses in all five health centres visited.
Household costs. Household cost data was collected from September 2010 to June 2012 in
a randomly selected sample of study children experiencing a fever episode.Main caregivers of
the children were interviewedat the time of their visit to a study health centre with a febrile
child and then again interviewed in their homes on days 3 and 7 by a trained interviewer. A
total of 2006 febrile episodes was included for household cost interviews–885 in the test-based
arm and 1121 in the clinical judgement arm. The purpose of these interviewswas to capture
information on household costs for transport, drugs, consultation fees, laboratory fees and
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special foods purchased to improve the health of the child, incurred at the initial visit at the
health centre, and additional treatment-seeking visits to any health provider to manage the
febrile episode. To avoid double counting, any fees paid by the household to public health cen-
tres were excluded as resources for these services had already been captured in the health centre
costing component. In addition, main caregivers were asked how much time had been used per
trip for travelling to health providers and if the illness of the child had resulted in days where
the main caregiver was unable to perform usual activities. This opportunity cost of time was
valued at US$1.14 per person per day equal to the salary per day for females working in agricul-
ture in rural areas in 2013 adjusted to the 2011 price level [31].
Incremental cost-effectiveness analysis
Costs were not collected at the individual level for all children enrolled in the trial [32] so the
cost-effectiveness analysis was developed using a decision analytical approach [33]. Data on
the costs and effects by arm were captured from a number of sources as described above and
were linked utilising the decision trees by arm displayed in Figs 1 and 2. Probabilities of deci-
sion tree branches of malaria (reference diagnosis), mRDT or clinical diagnosis result and
adherence to mRDT result were derived using outcomes from the cluster-randomised trial
Fig 1. Decision tree for children with fever visiting public health centres offering malaria diagnosis
by rapid diagnostic test, Kintampo District, Ghana.
doi:10.1371/journal.pone.0164055.g001
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[23]. At the end of the decision tree, the treatment of fever episodes could be classified as
appropriate or not according to the study definition (child with positive reference diagnosis
prescribed a course of ACT or child with negative reference diagnosis not given an ACT).
Some febrile children sought additional treatment after the first visit to a public health centre.
The probability of seeking additional care within a one-week periodwas obtained from the
household cost interviews.All probabilities used are listed in Table 1.
Societal and health sector costs by study arm were calculated by attaching cost data to the
decision trees with the cost data described above. Training and supervision costs estimated for
the two-year trial period by study arm were divided by the number of fever episodes included
during the trial time to arrive at an average unit cost per fever episode. Relevant services in
public health centres includedmRDT diagnosis and treatment in the outpatient department
with ACT, antibiotics or other drugs. The mean of unit costs from five health centres were
used in the decisionmodels. Average household expenditure on travel, drugs and fees
incurred during additional treatment-seeking within a one-week period after the initial visit
to a public health centre were obtained from the household cost interviews in a sub-sample of
trial participants. Time lost due to travelling to health providers, waiting and caring for ill
children were self-reported from the household cost home interviews and valued at US$1.14
per day. All average costs per fever episode or health centre visit utilised in the decisionmod-
els are listed in Table 1.
Total costs and effects were calculated for a simulated number of 1000 fever episodes in each
study arm by letting these pass through the decision trees populated with event probabilities
and cost data as described above. The incremental cost-effectiveness ratio (ICER) was obtained
by subtracting total costs in the control arm from the total costs in the intervention arm (numer-
ator) and subtracting the total effectmeasured as appropriately treated children in the control
arm from total effect in the intervention arm (denominator). The ICER therefore showed the
cost per additional appropriately treated fever episode when test-basedmanagement of malaria
was introduced into public health centres which previously used clinical diagnosis.
Fig 2. Decision tree for children with fever visiting public health centres offering malaria diagnosis
by clinical judgement, Kintampo District, Ghana.
doi:10.1371/journal.pone.0164055.g002
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Sensitivity analysis
One-way sensitivity analyses were undertaken to examine how sensitive the ICER of introduc-
ing mRDT diagnosis in public health centres was to changes in important parameters and
assumptions. These includedmalaria prevalence, mRDT accuracy, adherence to mRDT result
by health workers, prices of mRDT and ACT, opportunity cost of lost time and a range of
health sector unit costs. A two-way sensitivity analysis was performed on mRDT accuracy
since an mRDT with high sensitivity will typically have a lower specificity and vice versa [34].
Probabilistic sensitivity analysis (PSA) was undertaken to assess the sensitivity of the ICER
to simultaneous variation in relevant parameters [33]. This was done by defining relevant
probability distributions to decisionmodel parameters rather than point estimates. A beta dis-
tribution was assigned to all the branch probabilities used in the decision trees such as ‘adher-
ence to mRDT result’ using trial data [23] to estimate distribution parameters. Gamma
distributions were used to describe the variation in all household cost categories due to the
non-negative, right-skewed nature of the data [33] and with distribution parameters estimated
from the household cost survey interviews. The remaining cost parameters like health centre
cost per visit entered the analysis as point estimates. An overviewof all distributions and point
estimates used in the PSA are listed in Table 1. Monte Carlo simulations were used to propa-
gate uncertainty by simultaneously selecting values from each parameter distribution by run-
ning 8000 iterations in Excel (Microsoft, Seattle)–a number of iterations found to ensure
reasonably stable mean ICERs [35]. Uncertainty surrounding the ICERs was summarised by
plotting joint incremental cost and incremental effects in the cost-effectiveness plane and
Table 1. Parameters utilised in decision model and distributions for probabilistic sensitivity analyses (PSA) for cost-effectiveness analysis of
introducing malaria rapid diagnostic tests in public health centres in Kintampo District, Ghana, 2011 (US$1 = GHS1.51).
-------------------------- Value -------------------------
Parameter Test-based approach Clinical judgement Source Distribution in PSA
Malaria prevalence among children with fever visiting health centres (%) 50.0 50.3 [23] Point estimate
Sensitivity of diagnosis (%) 94.7 87.7 [23] Beta
Specificity of diagnosis (%) 47.2 26.1 [23] Beta
Adherence to positive mRDT result (%) 97.8 NA [23] Beta
Adherence to negative mRDT result (%) 96.3 NA [23] Beta
Training of health workers, cost per fever episode (US$) 1.7 1.6 λ Point estimate
Supervision, cost per fever episode (US$) 0.4 0.4 λ Point estimate
mRDT diagnosis in health centres, cost per visit (US$) 2.6 0.0 β Point estimate
Treatment with ACT in health centres, cost per visit (US$) 5.9 5.9 β Point estimate
Treatment with antibiotics in health centres, cost per visit (US$) 4.5 4.5 β Point estimate
Treatment with other drugs in health centres, cost per visit (US$) 4.1 4.1 β Point estimate
Probability of additional treatment seeking after health centre visit (%) 11.4 19.4 α Beta
Out-of-pocket expenditure on additional treatment-seeking (US$) 2.0 1.8 α Gamma
Opportunity cost of travel time for additional treatment-seeking (US$) 0.1 0.2 α Gamma
Out-of-pocket expenditure on special foods, per fever episode (US$) 0.7 1.0 α Gamma
Opportunity cost of days not able to work, per fever episode (US$) 4.6 5.1 α Gamma
Value of lost time per day, assumption (US$) 1.1 1.1 [31] Point estimate
λ Study accounting system for the trial [23].
β Primary data collection in five public health centres in Kintampo District. The mean of unit costs in five health centres.
α Interview survey conducted among 2006 households in Kintampo District that experienced a fever episode in a child below 5 years and visited a public
health centre.
doi:10.1371/journal.pone.0164055.t001
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quantified by calculating confidence intervals and cost-effectiveness acceptability curves
(CEACs) [36–39] where the latter showed the probability that the introduction of mRDTs in
public health centres was cost-effective given different levels of a health policymaker’s hypo-
thetical willingness to pay for an appropriately treated fever episode.
Ethical issues
The study was approved by the ethics review committees of the Ghana Health Service, the Kin-
tampo Health Research Centre and the London School of Hygiene and Tropical Medicine.
Administrative approval was obtained from the respective district and hospital management
teams, while health workers gave oral consent. Individual informed consent was obtained from
all care givers. Signed (thumb printed if unable to read or write in English) informed consent
was obtained from each caregiver prior to enrolment of the child. This consent procedure was
approved by all mentioned ethical review committees.
Table 2. Cost and effects normalised to 1000 fever episodes by study arm and incremental cost-effectiveness ratio of replacing clinical diagnosis
of malaria by rapid diagnostic tests in public health centres in Kintampo District, Ghana, 2011 (US$1 = GHS1.51).
Test-based
approach
Clinical judgement
N % N %
Fever episodes 1,000 100 1,000 100
Treated with ACT 732 73 808 81
Appropriately treated # 704 70 570 57
Reference diagnosis malaria positive 500 50 503 50
US$ % US$ %
Health sector cost per 1000 fever episodes 10,484 64 7,992 54
Training of health care workers 1,721 11 1,576 11
Supervision 478 3 590 4
mRDT diagnosis in health centres € 2,616 16 0 0
Treatment with ACT in health centres β 3,554 22 3,813 26
Treatment with antibiotics in health centres β 1,944 12 1,865 13
Treatment with other drugs in health centres β 171 1 147 1
Household cost per 1000 fever episodes 5,873 36 6,891 46
Drugs, fees, travel (out-of-pocket) λ 395 2 580 4
Special foods (out-of-pocket) 700 4 1,049 7
Time lost (opportunity cost) 4,778 29 5,262 35
Total societal cost per 1000 fever episodes 16,358 100 14,883 100
Incremental analysis (replace clinical judgement by test-based approach for 1000 fever episodes)
Incremental number of appropriately treated [95% CI] 134 [120; 148]
Incremental health sector cost, US$ [95% CI] 2,492 [2,467; 2,517]
Incremental societal cost, US$ [95% CI] 1,474 [-8,208; 11,767]
ICER health sector perspective, US$ [95% CI] 18.6 [16.7; 20.9]
ICER societal perspective, US$ [95% CI] 11.0 [-61.4; 87.3]
# Children with a positive reference diagnosis prescribed an ACT or children with a negative reference diagnosis not prescribed an ACT.
€ All resources required to perform diagnosis with mRDT in public health centre.
β All resources required to conduct treatment in outpatient department in public health centre.
λ First visit to a study health centre and subsequent treatment seeking to any health provider within 7 days.
doi:10.1371/journal.pone.0164055.t002
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Results
The availability of mRDTs for malaria diagnosis resulted in fewer ACT treatments compared
to the clinical judgement approach (73% versus 81%) and more children appropriately treated
(70% versus 57%) according to the definition utilised in this study (Table 2). Health sector
costs per 1000 fever episodes in the test-based arm were 31% higher than in the clinical judge-
ment arm (US$10,484 versus $7,992) mainly due to the extra costs of the mRDTs and the extra
personnel and other resources required to perform the test in public health centres. Cost sav-
ings from the lower proportion of febrile children treated with an ACT in the test-based arm
compared to the clinical judgement arm was US$259 per 1000 fever episodes and covered only
10% of the extra cost of mRDT diagnosis.
With regards to costs borne by households, patients in the clinical judgment arm incurred
considerably higher household cost per 1000 fever episodes than test-based arm (US$6,891 ver-
sus $5,873). This was due to the finding that a higher proportion of caregivers of children in
the clinical judgement arm reported additional alternative treatment seeking (19% versus 11%,
Table 1), more special foods were purchased and more days unable to do normal activities
were experienced.The most important household cost component in both arms was the value
of time lost by family caregivers for looking after their ill child. Total societal cost combining
health sector and household cost for the test-based approach arm was US$16,358 for 1000
fever patients compared to US$14,883 in the clinical judgement arm. Household costs formed
a high share of total societal costs in both arms; 36% in the test-based approach and 46% in the
clinical judgement arm.
The introduction of diagnosis of malaria by mRDT instead of clinical judgement was esti-
mated to lead to an increase of 134 appropriately treated patients (95% CI 120 to 148) in a pop-
ulation of 1000 fever patients (Table 2). The incremental cost of introducingmRDTs in public
health centres per 1000 fever episodes was US$2,492 (95% CI US$2,467 to US$2,517) from a
health sector perspective and US$1,474 (95% CI -US$8,208 to US$11,767) from a societal per-
spective. The ICER from a health sector perspectivewas found to be US$18.6 (95% CI US$16.7
to US$20.9) meaning that the introduction of mRDT-based diagnosis would cost the Ministry
of Health US$18.6 per extra appropriately treated child under five compared to clinical judge-
ment. The ICER from a societal perspectivewas lower at US$11.0 (95% CI -61.4 to 87.3) per
appropriately treated child.
The one-way sensitivity analyses showed that the ICERs from both the health sector and the
societal perspectiveswere robust to changes in the parameters investigated with a few excep-
tions (Table 3). A decrease in the adherence to negative mRDT results from the observed96%
to 70% or below increased the ICERs by more than 80% thereby making the introduction of
mRDTs less cost-effective. Similarly, if the malaria prevalence among children with fever had
been 80% rather than the observed50%, then the ICERs would have been around 60% higher
makingmRDT diagnosis less attractive from a cost-effectiveness perspective.An improvement
of mRDT specificity from 47% to 75% or above would decrease the ICERs by more than 50%
thus resulting in mRDTs becomingmore cost-effective relative to presumptive diagnosis.
ICERs were less sensitive to the remaining individual parameters investigated. The two-way
sensitivity analysis of mRDT accuracy varying simultaneously the sensitivity and specificity
suggested that the ICERs were insensitive to this aspect (Table 3).
The results of the probabilistic sensitivity analyses are presented in Figs 3 and 4. From a
health sector perspective, all pairs of incremental health sector cost and effects were situated
in the north-eastern quadrant of the cost-effectiveness plane meaning that the change in
number of appropriately treated children was always positive and incremental health sector
cost always positive if mRDTs were introduced (Fig 3, Panel a). The cost-effectiveness
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acceptability curve (CEAC) from a health sector perspective (Fig 3, Panel b) displayed the
probability that the introduction of mRDTs in public health centres was cost-effective given
different levels of a health policymaker’s hypothetical willingness to pay (WTP) for an
appropriately treated fever episode. If the health policymaker was willing to pay at least US
$20 per appropriately treated child, the probability of mRDT introduction being a cost-effec-
tive intervention was 90% with this probability becoming 98% and 100% if WTP was US$21
and US$22. From a societal perspective, the cost-effectiveness scatter plot exhibited consider-
ably more variation (uncertainty) in costs compared to the health sector perspective as seen
by much larger spread and spanning both positive and negative incremental societal costs
(Fig 4, Panel a). In the south-eastern quadrant where the mRDT intervention had a higher
number of appropriately treated fever episodes and lower costs than the clinical judgement
intervention, the introduction of mRDTs would therefore be the dominant intervention from
Table 3. Sensitivity to selected parameters of the incremental cost-effectiveness ratio (ICER) of replacing clinical diagnosis of malaria by rapid
diagnostic tests in public health centres in Kintampo District, Ghana, July 2010-June 2012 (US$1 = GHS1.51).
------------------ ICER in US$ ----------------- ------------------ ICER in US$ -----------------
Parameter & Health sector Societal Parameter & Health sector Societal
Malaria prevalence among children with fever
(50%)
Health centre cost per visit excl drugs and mRDTs
20% 13.0 7.4 40% lower 13.9 6.3
30% 14.5 8.3 20% lower 16.2 8.7
40% 16.2 9.5 20% higher 20.9 13.3
60% 21.1 12.6 40% higher 23.3 15.7
70% 24.6 14.9 Training and supervision cost per episode
mRDT sensitivity (95%) 40% lower 18,1 10.5
80% 36.3 20.7 20% lower 18.3 10.8
90% 21.9 12.8 20% higher 18.8 11.2
100% 16.0 9.6 40% higher 19.1 11.5
mRDT specificity (47%) Opportunity cost per day (US$1.14)
75% 8.6 4.8 US$0.00 18.6 14.6
90% 6.5 3.4 US$0.50 18.6 13.0
100% 5.5 2.8 US$1.00 18.6 11.4
Sensitivity / specificity US$1.50 18,6 9.8
100% / 40% 20.7 12.5 US$2.00 18.6 8.2
90% / 50% 19.4 11.3 US$2.50 18.6 6.7
80% / 60% 18.2 10.0 Probability of additional treatment-seeking in test-based arm (11%)
60% 46.5 28.7 5% 18.6 10.0
70% 33.5 20.4 20% 18.6 12.4
80% 25.9 15.6 30% 18.6 14.0
mRDT price (US$0.82) Probability of additional treatment-seeking in clinical judgement arm
(19%)
US$0.20 13.6 6.0 5% 18.6 13.1
US$0.40 15.1 7.5 20% 18.6 10.9
US$0.60 16.6 9.0 30% 18.6 9.4
ACT price (US$1.32) Various household costs per episode
US$1.00 18.8 11.2 Special food equal by arm 18.6 13.6
US$1.20 18.7 11.1 Days lost equal by arm 18.6 14.3
& Central parameter values are shown in parentheses.
doi:10.1371/journal.pone.0164055.t003
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a cost-effectiveness viewpoint. According to the CEAC from a societal perspective (Fig 4,
Panel b), if the WTP of a policymaker was US$20, the probability that mRDT introduction
was cost-effectivewould be 62% increasing to 72% and 81% if the WTP was US$30 and US
$40 respectively.
Discussion
This cost-effectiveness analysis used a decisionmodel populated with primary data from a clus-
ter-randomised trial [23] supplemented with cost data collected in Ghana. The aim was to
Fig 3. Probabilistic sensitivity analysis (health sector perspective): (a) scatter plot of incremental
health sector cost in US$ and incremental number of appropriately treated fever episodes resulting
from replacing clinical diagnosis of malaria by rapid diagnostic test, 2011 (US$1 = GHS1.51) and (b)
cost-effectiveness acceptability curve.
doi:10.1371/journal.pone.0164055.g003
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evaluate the cost-effectiveness of introducingmRDTs in lower level public health centres
where malaria diagnosis was typically presumptive.
The results of this research provided support for the introduction of mRDTs in public
health centres instead of presumptive malaria diagnosis. Test-based management of suspected
malaria led to an increase in appropriately treated children by 13.4 percentage points compared
to clinical judgement. This improvement was obtained at low cost to the health sector of US
$18.6 per additional appropriately treated child and even lower societal cost of US$11.0 per
appropriately treated child if costs borne by households were included. In addition, the extra
Fig 4. Probabilistic sensitivity analysis (societal perspective): (a) scatter plot of incremental societal
cost in US$ and incremental number of appropriately treated fever episodes resulting from replacing
clinical diagnosis of malaria by rapid diagnostic test, 2011 (US$1 = GHS1.51) and (b) cost-
effectiveness acceptability curve.
doi:10.1371/journal.pone.0164055.g004
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cost per child with fever managed with mRDT rather than presumptively was only US$2.49
from a health sector perspective and US$1.47 from a societal perspective.A study conducted in
public health centres in another area of Ghana found that the incremental cost per appropri-
ately treated fever patient was US$10.5 from the health sector perspective and US$8.5 from a
societal perspective [16]. In Afghanistan with extremely low malaria transmission, incremental
cost per appropriately treated fever patient was estimated to be US$2.5 and US$4.5 from the
health sector and societal perspectives respectively [40]. A possible reason for the higher ICER
levels in Kintampo compared to the other studies was highmalaria positivity rate among chil-
dren with fever. High malaria transmission will tend to limit the potential of mRDTs to
improve appropriate malaria treatment compared to clinical judgement and therefore increase
the ICER level. While the ICER levels in Kintampo therefore appear to be at the high end com-
pared to other studies which were conducted in areas with lower malaria transmission, it will
ultimately be up to health policymakers in Ghana to decide if the level of cost per extra appro-
priately treated fever child found in this study is good use of government and societal resources
compared to competing beneficial health interventions.
While ICERs were robust to variations in most of the model parameters, the one-way sensi-
tivity analyses also identified aspects worth considering before deciding to introducemRDTs.
First, a high adherence to mRDT results was essential to ensure the relative cost-effectiveness
of mRDTs over clinical judgement and an almost complete adherence to negative mRDTs was
found in this study due to the trial setting. A decline in adherence to negative mRDTs to 50%
as experienced in another study in Ghana [16] would lead to more than doubling the ICERs of
the present study. This suggests that efforts to maintain high adherence among health person-
nel such as regular or thorough training could be valuable use of resources as found in a study
in Cameroon [41]. Second, it was important that the mRDT chosen was of high accuracy to
ensure appropriate treatment and reduced ACT cost. If the mRDT specificity had been 90%
rather than the actual 47% of this study, then the introduction of mRDTs would have decreased
ACT cost by 34% instead of the actual 9% observed and improved the cost-effectiveness of
mRDTs. Third, ICERs were sensitive to the level of malaria positivity rate among children visit-
ing health centres. The lower the positivity rate, the more cost-effectivemRDTs were found to
be. At positivity rates considerably higher than the 50% found in the present study such as 80%
or 90%, the introduction of mRDTs would become increasingly more questionable from a
cost-effectiveness viewpoint. However, with the increased efforts for elimination of malaria,
the positivity of malaria among fever cases is likely to decrease and thus decrease the ICER.
Household cost borne by families to children in the mRDT arm was lower than in the clini-
cal judgement arm explaining why the ICER was lower from a societal perspective compared
to a health sector viewpoint (US$11.0 versus US$18.6). However, this research also found large
variation in household costs in both arms leading as a consequence to a large variation in socie-
tal cost as displayed in Fig 4 (Panel a) and the wide confidence interval for incremental societal
cost. Such high variation in household cost led to higher uncertainty for the health policymak-
ers in the decision to introducemRDTs or not from a societal viewpoint: If the value per appro-
priately treated child was agreed to be US$20, then there was a 90% probability that the
introduction of mRDTs was a cost-effective intervention from a health sector perspective (Fig
3, Panel b) while there was only a 62% probability that the introduction of mRDTs was cost-
effective from a societal perspectivewhere the impact on households were also taken into con-
sideration (Fig 4, Panel b). There might be several possible explanations for this variation in
household cost. First, there could genuinely be a large variation in responses to children’s ill-
nesses in individual households with respect to additional treatment-seeking, purchasing food
believed to help the child to become better and taking time to care for an ill child. Recall bias
on out-of-pocket expenditure and time utilised should be minimal as interviewswere
Cost-Effectiveness Analysis of Test-Based versus Presumptive Treatment of Malaria in Ghana
PLOS ONE | DOI:10.1371/journal.pone.0164055 October 3, 2016 14 / 18
conducted at the time of health centre visit and subsequently in the homes of the children with
fever 3 and 7 days later. Respondents therefore only had to remember a few days back in time.
Second, there were other possible factors contributing to the variation in household cost. For
instance, respondents might find it difficult to give an exact estimate on ‘the number of days
unable to perform normal activities’ since caring for the child might not take up the whole day
enabling family members to perform some of their normal activities. This question may there-
fore be open to different interpretations by respondents. An analysis of the replies to this par-
ticular question suggested that some respondents equated the time unable to do normal
activities as the full illness period of the child while other respondents gave a reply correspond-
ing to the days where the child was severely ill and in need of much care. Further, household
cost interviewswere conducted across the year thereby incorporating both high and low
malaria transmission periods. The response to fever illnesses and thereby household cost could
be different in the high and the low season introducing variation in (average) household cost.
This study estimated an ICER from a societal perspective that was close to half the level of
the ICER from the health sector perspective. This finding highlighted the importance of taking
the wider societal perspective in a cost-effectiveness analysis incorporating the cost borne by
other sectors of the economy than the health sector, in particular households affected by an
intervention. The introduction of mRDTs increased the cost to the health care sector despite
lower cost from reduced ACT consumption compared to clinical judgement of malaria. At the
same time, this study suggested that the utilisation of mRDTs at health centres lessened the
burden on households thereby leading to a reduction of societal cost. Families in the mRDT
arm experienced lower out-of-pocket expenditure due to a reported lower tendency to seek
extra care after a health centre visit and fewer days occupied by taking care of ill children. An
added advantage to families in the mRDT arm was a lower risk of exposure to health providers
such as drug shops where parasitological diagnosis is rarely available and less effective antima-
larials are often sold [42]. As mentioned earlier, high variation in household cost was experi-
enced in the sample of 2006 household interviewswhich constituted only 18% of the total
episodes incorporated in the trial to measure the effect. This suggested investing in a higher
sample size for investigating household cost in future studies.
Limitations
The research project provided freemembership of the National Health Insurance Scheme (NHIS)
to all households with children participating in the trial. This effectively reduced the point-of-care
costs for the households when seeking care (at accredited health providers) especially among
households that had not planned to purchase insurancemembership during the trial period.This
might have led to a different treatment-seeking behaviour and lower reported household costs
compared to a non-trial situation. However, reduced point-of-care costs may bemore common in
the future as membership of the NHIS is compulsory and the share of households being scheme
members will likely increase and eventually cover the majority of the population.
The cost of hospital inpatient care was not included in the analysis even though the unit
cost of an inpatient stay would be much higher than a health centre outpatient visit. Trial data
suggested that the number of admissions for inpatient care was low and at similar levels in the
two study arms. The measurement and inclusion of hospital inpatient costs was therefore
unlikely to change the conclusions made.
Conclusions
The introduction of mRDTs into public health centres is likely to be considered a cost-effective
intervention in this high malaria transmission setting: a test-based diagnosis led to a higher
Cost-Effectiveness Analysis of Test-Based versus Presumptive Treatment of Malaria in Ghana
PLOS ONE | DOI:10.1371/journal.pone.0164055 October 3, 2016 15 / 18
number of appropriately treated fever episodes compared to clinical judgement at relatively
low health sector cost of US$18.6 per additional fever episode appropriately treated and even
lower societal cost of US$11.0.Whether this cost is sufficiently low compared to the cost of
other competing, beneficial health sector interventions will ultimately be the decision of policy
makers in Ghana, and other countries with similar levels of malaria transmission and health
system. The relative cost-effectiveness of a test-based approach could be improved further if an
mRDT is identifiedwith higher specificitywithout compromising its sensitivity. The test-based
approach also appeared to be a benefit to families as caregivers reported lower levels of out-of-
pocket expenditure and less time utilised for caring for ill children if they had visited a health
centre offeringmRDT diagnosis compared to households who attended health centres with
clinical management of malaria.
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